APO Research
Talk to an analyst

APO RESEARCH · REPORT

Drug Stability Testing Services

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Drug Stability Testing Services Market Analysis and Forecast 2026-2032

17 January 2026196 pages

Choose your research edition.

Industry ResearchDrug Stability Testing Services Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Drug Stability Testing Services Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Drug Stability Testing Services Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Drug Stability Testing Services Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Drug Stability Testing Services Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Drug Stability Testing Services market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Drug Stability Testing Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Drug Stability Testing Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Drug Stability Testing Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Drug Stability Testing Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Drug Stability Testing Services include SGS, Nelson Labs, Q Laboratories, Auriga Research, Intertek, Catalent, Pace Analytical, Charles River Laboratories and Impact Analytical, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Drug Stability Testing Services, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Drug Stability Testing Services, also provides the revenue of main regions and countries. Of the upcoming market potential for Drug Stability Testing Services, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Drug Stability Testing Services revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Drug Stability Testing Services market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Drug Stability Testing Services revenue, projected growth trends, production technology, application and end-user industry.

Drug Stability Testing Services Segment by Company

SGS

Nelson Labs

Q Laboratories

Auriga Research

Intertek

Catalent

Pace Analytical

Charles River Laboratories

Impact Analytical

Prolytix

Almac

Galbraith Laboratories, Inc.

Element

Drug Stability Testing Services Segment by Type

Early Development Stability Testing Services

Clinical Stability Testing Services

Predictive Stability Testing Services

In-use Stability Testing Services

Others

Drug Stability Testing Services Segment by Application

Pharmaceuticals

Biologics

Others

Drug Stability Testing Services Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drug Stability Testing Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Drug Stability Testing Services and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drug Stability Testing Services.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Drug Stability Testing Services in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Drug Stability Testing Services company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Drug Stability Testing Services revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Drug Stability Testing Services Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Early Development Stability Testing Services Major Player Table 3. Clinical Stability Testing Services Major Player Table 4. Predictive Stability Testing Services Major Player Table 5. In-use Stability Testing Services Major Player Table 6. Others Major Player Table 7. Global Drug Stability Testing Services Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 8. Pharmaceuticals Major Player Table 9. Biologics Major Player Table 10. Others Major Player Table 11. Drug Stability Testing Services Industry Trends Table 12. Drug Stability Testing Services Industry Drivers Table 13. Drug Stability Testing Services Industry Opportunities and Challenges Table 14. Drug Stability Testing Services Industry Restraints Table 15. Global Drug Stability Testing Services Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 16. Global Drug Stability Testing Services Market Size by Region (2021-2026) & (US$ Million) Table 17. Global Drug Stability Testing Services Market Share by Region (2021-2026) Table 18. Global Drug Stability Testing Services Market Size by Region (2027-2032) & (US$ Million) Table 19. Global Drug Stability Testing Services Market Share by Region (2027-2032) Table 20. Global Drug Stability Testing Services Revenue by Players (US$ Million) & (2021-2026) Table 21. Global Drug Stability Testing Services Revenue Market Share by Players (2021-2026) Table 22. Global Drug Stability Testing Services Key Players Ranking, 2024 VS 2025 VS 2026 Table 23. Global Drug Stability Testing Services Key Players Headquarters & Area Served Table 24. Global Drug Stability Testing Services Players, Product Type & Application Table 25. Global Drug Stability Testing Services Players Establishment Date Table 26. Global Players Market Concentration Ratio (CR5 and HHI) Table 27. Global Drug Stability Testing Services by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 28. Global Drug Stability Testing Services Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Drug Stability Testing Services Revenue by Type (2021-2026) & (US$ Million) Table 30. Global Drug Stability Testing Services Revenue by Type (2027-2032) & (US$ Million) Table 31. Global Drug Stability Testing Services Revenue Market Share by Type (2021-2026) Table 32. Global Drug Stability Testing Services Revenue Market Share by Type (2027-2032) Table 33. Global Drug Stability Testing Services Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Drug Stability Testing Services Revenue by Application (2021-2026) & (US$ Million) Table 35. Global Drug Stability Testing Services Revenue by Application (2027-2032) & (US$ Million) Table 36. Global Drug Stability Testing Services Revenue Market Share by Application (2021-2026) Table 37. Global Drug Stability Testing Services Revenue Market Share by Application (2027-2032) Table 38. SGS Company Information Table 39. SGS Business Overview Table 40. SGS Drug Stability Testing Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 41. SGS Drug Stability Testing Services Product Portfolio Table 42. SGS Recent Development Table 43. Nelson Labs Company Information Table 44. Nelson Labs Business Overview Table 45. Nelson Labs Drug Stability Testing Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 46. Nelson Labs Drug Stability Testing Services Product Portfolio Table 47. Nelson Labs Recent Development Table 48. Q Laboratories Company Information Table 49. Q Laboratories Business Overview Table 50. Q Laboratories Drug Stability Testing Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 51. Q Laboratories Drug Stability Testing Services Product Portfolio Table 52. Q Laboratories Recent Development Table 53. Auriga Research Company Information Table 54. Auriga Research Business Overview Table 55. Auriga Research Drug Stability Testing Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 56. Auriga Research Drug Stability Testing Services Product Portfolio Table 57. Auriga Research Recent Development Table 58. Intertek Company Information Table 59. Intertek Business Overview Table 60. Intertek Drug Stability Testing Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 61. Intertek Drug Stability Testing Services Product Portfolio Table 62. Intertek Recent Development Table 63. Catalent Company Information Table 64. Catalent Business Overview Table 65. Catalent Drug Stability Testing Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 66. Catalent Drug Stability Testing Services Product Portfolio Table 67. Catalent Recent Development Table 68. Pace Analytical Company Information Table 69. Pace Analytical Business Overview Table 70. Pace Analytical Drug Stability Testing Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 71. Pace Analytical Drug Stability Testing Services Product Portfolio Table 72. Pace Analytical Recent Development Table 73. Charles River Laboratories Company Information Table 74. Charles River Laboratories Business Overview Table 75. Charles River Laboratories Drug Stability Testing Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 76. Charles River Laboratories Drug Stability Testing Services Product Portfolio Table 77. Charles River Laboratories Recent Development Table 78. Impact Analytical Company Information Table 79. Impact Analytical Business Overview Table 80. Impact Analytical Drug Stability Testing Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 81. Impact Analytical Drug Stability Testing Services Product Portfolio Table 82. Impact Analytical Recent Development Table 83. Prolytix Company Information Table 84. Prolytix Business Overview Table 85. Prolytix Drug Stability Testing Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 86. Prolytix Drug Stability Testing Services Product Portfolio Table 87. Prolytix Recent Development Table 88. Almac Company Information Table 89. Almac Business Overview Table 90. Almac Drug Stability Testing Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 91. Almac Drug Stability Testing Services Product Portfolio Table 92. Almac Recent Development Table 93. Galbraith Laboratories, Inc. Company Information Table 94. Galbraith Laboratories, Inc. Business Overview Table 95. Galbraith Laboratories, Inc. Drug Stability Testing Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 96. Galbraith Laboratories, Inc. Drug Stability Testing Services Product Portfolio Table 97. Galbraith Laboratories, Inc. Recent Development Table 98. Element Company Information Table 99. Element Business Overview Table 100. Element Drug Stability Testing Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 101. Element Drug Stability Testing Services Product Portfolio Table 102. Element Recent Development Table 103. North America Drug Stability Testing Services Revenue by Type (2021-2026) & (US$ Million) Table 104. North America Drug Stability Testing Services Revenue by Type (2027-2032) & (US$ Million) Table 105. North America Drug Stability Testing Services Revenue by Application (2021-2026) & (US$ Million) Table 106. North America Drug Stability Testing Services Revenue by Application (2027-2032) & (US$ Million) Table 107. North America Drug Stability Testing Services Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 108. North America Drug Stability Testing Services Revenue by Country (2021-2026) & (US$ Million) Table 109. North America Drug Stability Testing Services Revenue by Country (US$ Million) & (2027-2032) Table 110. Europe Drug Stability Testing Services Revenue by Type (2021-2026) & (US$ Million) Table 111. Europe Drug Stability Testing Services Revenue by Type (2027-2032) & (US$ Million) Table 112. Europe Drug Stability Testing Services Revenue by Application (2021-2026) & (US$ Million) Table 113. Europe Drug Stability Testing Services Revenue by Application (2027-2032) & (US$ Million) Table 114. Europe Drug Stability Testing Services Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 115. Europe Drug Stability Testing Services Revenue by Country (2021-2026) & (US$ Million) Table 116. Europe Drug Stability Testing Services Revenue by Country (US$ Million) & (2027-2032) Table 117. China Drug Stability Testing Services Revenue by Type (2021-2026) & (US$ Million) Table 118. China Drug Stability Testing Services Revenue by Type (2027-2032) & (US$ Million) Table 119. China Drug Stability Testing Services Revenue by Application (2021-2026) & (US$ Million) Table 120. China Drug Stability Testing Services Revenue by Application (2027-2032) & (US$ Million) Table 121. Asia Drug Stability Testing Services Revenue by Type (2021-2026) & (US$ Million) Table 122. Asia Drug Stability Testing Services Revenue by Type (2027-2032) & (US$ Million) Table 123. Asia Drug Stability Testing Services Revenue by Application (2021-2026) & (US$ Million) Table 124. Asia Drug Stability Testing Services Revenue by Application (2027-2032) & (US$ Million) Table 125. Asia Drug Stability Testing Services Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 126. Asia Drug Stability Testing Services Revenue by Region (US$ Million) & (2021-2026) Table 127. Asia Drug Stability Testing Services Revenue by Region (US$ Million) & (2027-2032) Table 128. SAMEA Drug Stability Testing Services Revenue by Type (2021-2026) & (US$ Million) Table 129. SAMEA Drug Stability Testing Services Revenue by Type (2027-2032) & (US$ Million) Table 130. SAMEA Drug Stability Testing Services Revenue by Application (2021-2026) & (US$ Million) Table 131. SAMEA Drug Stability Testing Services Revenue by Application (2027-2032) & (US$ Million) Table 132. SAMEA Drug Stability Testing Services Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 133. SAMEA Drug Stability Testing Services Revenue by Country (2021-2026) & (US$ Million) Table 134. SAMEA Drug Stability Testing Services Revenue by Country (US$ Million) & (2027-2032) Table 135. Research Programs/Design for This Report Table 136. Authors List of This Report Table 137. Secondary Sources Table 138. Primary Sources List of Figures Figure 1. Drug Stability Testing Services Image Figure 2. Global Drug Stability Testing Services Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Drug Stability Testing Services Market Size Share 2021 VS 2025 VS 2032 Figure 4. Early Development Stability Testing Services Image Figure 5. Clinical Stability Testing Services Image Figure 6. Predictive Stability Testing Services Image Figure 7. In-use Stability Testing Services Image Figure 8. Others Image Figure 9. Global Drug Stability Testing Services Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 10. Global Drug Stability Testing Services Market Size Share 2021 VS 2025 VS 2032 Figure 11. Pharmaceuticals Image Figure 12. Biologics Image Figure 13. Others Image Figure 14. Global Drug Stability Testing Services Market Size (US$ Million) & (2021-2032) Figure 15. Global Drug Stability Testing Services Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global Drug Stability Testing Services Market Share by Region: 2021 VS 2025 VS 2032 Figure 17. Global Drug Stability Testing Services Players Revenue Share Top 10 and Top 5 in 2025 Figure 18. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Drug Stability Testing Services Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Drug Stability Testing Services Revenue Market Share 2021 VS 2025 VS 2032 Figure 21. Global Drug Stability Testing Services Revenue Market Share by Type (2021-2032) Figure 22. Global Drug Stability Testing Services Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Drug Stability Testing Services Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 24. Global Drug Stability Testing Services Revenue Market Share by Application (2021-2032) Figure 25. North America Drug Stability Testing Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 26. North America Drug Stability Testing Services Revenue Share by Type (2021-2032) Figure 27. North America Drug Stability Testing Services Revenue Share by Application (2021-2032) Figure 28. North America Drug Stability Testing Services Revenue Share by Country (2021-2032) Figure 29. United States Drug Stability Testing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Canada Drug Stability Testing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Mexico Drug Stability Testing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 32. Europe Drug Stability Testing Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 33. Europe Drug Stability Testing Services Revenue Share by Type (2021-2032) Figure 34. Europe Drug Stability Testing Services Revenue Share by Application (2021-2032) Figure 35. Europe Drug Stability Testing Services Revenue Share by Country (2021-2032) Figure 36. Germany Drug Stability Testing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. France Drug Stability Testing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. U.K. Drug Stability Testing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Italy Drug Stability Testing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Spain Drug Stability Testing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Russia Drug Stability Testing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Netherlands Drug Stability Testing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Nordic Countries Drug Stability Testing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. China Drug Stability Testing Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. China Drug Stability Testing Services Revenue Share by Type (2021-2032) Figure 46. China Drug Stability Testing Services Revenue Share by Application (2021-2032) Figure 47. Asia Drug Stability Testing Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 48. Asia Drug Stability Testing Services Revenue Share by Type (2021-2032) Figure 49. Asia Drug Stability Testing Services Revenue Share by Application (2021-2032) Figure 50. Asia Drug Stability Testing Services Revenue Share by Region (2021-2032) Figure 51. Japan Drug Stability Testing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. South Korea Drug Stability Testing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. India Drug Stability Testing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Australia Drug Stability Testing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Taiwan Drug Stability Testing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. Southeast Asia Drug Stability Testing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. SAMEA Drug Stability Testing Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 58. SAMEA Drug Stability Testing Services Revenue Share by Type (2021-2032) Figure 59. SAMEA Drug Stability Testing Services Revenue Share by Application (2021-2032) Figure 60. SAMEA Drug Stability Testing Services Revenue Share by Country (2021-2032) Figure 61. Brazil Drug Stability Testing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Argentina Drug Stability Testing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Chile Drug Stability Testing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Colombia Drug Stability Testing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Peru Drug Stability Testing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Saudi Arabia Drug Stability Testing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Israel Drug Stability Testing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. UAE Drug Stability Testing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Turkey Drug Stability Testing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Iran Drug Stability Testing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Egypt Drug Stability Testing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Early Development Stability Testing Services
  • Clinical Stability Testing Services
  • Predictive Stability Testing Services
  • In-use Stability Testing Services
  • Others
Applications
  • Pharmaceuticals
  • Biologics
  • Others
Companies covered
  • SGS
  • Nelson Labs
  • Q Laboratories
  • Auriga Research
  • Intertek
  • Catalent
  • Pace Analytical
  • Charles River Laboratories
  • Impact Analytical
  • Prolytix
  • Almac
  • Galbraith Laboratories, Inc.
  • Element

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Drug Stability Testing Services Market by Type
  3. 1.2.1 Global Drug Stability Testing Services Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Early Development Stability Testing Services
  5. 1.2.3 Clinical Stability Testing Services
  6. 1.2.4 Predictive Stability Testing Services
  7. 1.2.5 In-use Stability Testing Services
  8. 1.2.6 Others
  9. 1.3 Drug Stability Testing Services Market by Application
  10. 1.3.1 Global Drug Stability Testing Services Market Size by Application, 2021 VS 2025 VS 2032
  11. 1.3.2 Pharmaceuticals
  12. 1.3.3 Biologics
  13. 1.3.4 Others
  14. 1.4 Assumptions and Limitations
  15. 1.5 Study Goals and Objectives
2 Drug Stability Testing Services Market Dynamics
  1. 2.1 Drug Stability Testing Services Industry Trends
  2. 2.2 Drug Stability Testing Services Industry Drivers
  3. 2.3 Drug Stability Testing Services Industry Opportunities and Challenges
  4. 2.4 Drug Stability Testing Services Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Drug Stability Testing Services Market Perspective (2021-2032)
  2. 3.2 Global Drug Stability Testing Services Growth Trends by Region
  3. 3.2.1 Global Drug Stability Testing Services Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Drug Stability Testing Services Market Size by Region (2021-2026)
  5. 3.2.3 Global Drug Stability Testing Services Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Drug Stability Testing Services Revenue by Players
  2. 4.1.1 Global Drug Stability Testing Services Revenue by Players (2021-2026)
  3. 4.1.2 Global Drug Stability Testing Services Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Drug Stability Testing Services Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Drug Stability Testing Services Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Drug Stability Testing Services Key Players Headquarters & Area Served
  7. 4.4 Global Drug Stability Testing Services Players, Product Type & Application
  8. 4.5 Global Drug Stability Testing Services Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Drug Stability Testing Services Market CR5 and HHI
  11. 4.6.3 2025 Drug Stability Testing Services Tier 1, Tier 2, and Tier 3
5 Drug Stability Testing Services Market Size by Type
  1. 5.1 Global Drug Stability Testing Services Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Drug Stability Testing Services Revenue by Type (2021-2032)
  3. 5.3 Global Drug Stability Testing Services Revenue Market Share by Type (2021-2032)
6 Drug Stability Testing Services Market Size by Application
  1. 6.1 Global Drug Stability Testing Services Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Drug Stability Testing Services Revenue by Application (2021-2032)
  3. 6.3 Global Drug Stability Testing Services Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 SGS
  2. 7.1.1 SGS Company Information
  3. 7.1.2 SGS Business Overview
  4. 7.1.3 SGS Drug Stability Testing Services Revenue and Gross Margin (2021-2026)
  5. 7.1.4 SGS Drug Stability Testing Services Product Portfolio
  6. 7.1.5 SGS Recent Developments
  7. 7.2 Nelson Labs
  8. 7.2.1 Nelson Labs Company Information
  9. 7.2.2 Nelson Labs Business Overview
  10. 7.2.3 Nelson Labs Drug Stability Testing Services Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Nelson Labs Drug Stability Testing Services Product Portfolio
  12. 7.2.5 Nelson Labs Recent Developments
  13. 7.3 Q Laboratories
  14. 7.3.1 Q Laboratories Company Information
  15. 7.3.2 Q Laboratories Business Overview
  16. 7.3.3 Q Laboratories Drug Stability Testing Services Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Q Laboratories Drug Stability Testing Services Product Portfolio
  18. 7.3.5 Q Laboratories Recent Developments
  19. 7.4 Auriga Research
  20. 7.4.1 Auriga Research Company Information
  21. 7.4.2 Auriga Research Business Overview
  22. 7.4.3 Auriga Research Drug Stability Testing Services Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Auriga Research Drug Stability Testing Services Product Portfolio
  24. 7.4.5 Auriga Research Recent Developments
  25. 7.5 Intertek
  26. 7.5.1 Intertek Company Information
  27. 7.5.2 Intertek Business Overview
  28. 7.5.3 Intertek Drug Stability Testing Services Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Intertek Drug Stability Testing Services Product Portfolio
  30. 7.5.5 Intertek Recent Developments
  31. 7.6 Catalent
  32. 7.6.1 Catalent Company Information
  33. 7.6.2 Catalent Business Overview
  34. 7.6.3 Catalent Drug Stability Testing Services Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Catalent Drug Stability Testing Services Product Portfolio
  36. 7.6.5 Catalent Recent Developments
  37. 7.7 Pace Analytical
  38. 7.7.1 Pace Analytical Company Information
  39. 7.7.2 Pace Analytical Business Overview
  40. 7.7.3 Pace Analytical Drug Stability Testing Services Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Pace Analytical Drug Stability Testing Services Product Portfolio
  42. 7.7.5 Pace Analytical Recent Developments
  43. 7.8 Charles River Laboratories
  44. 7.8.1 Charles River Laboratories Company Information
  45. 7.8.2 Charles River Laboratories Business Overview
  46. 7.8.3 Charles River Laboratories Drug Stability Testing Services Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Charles River Laboratories Drug Stability Testing Services Product Portfolio
  48. 7.8.5 Charles River Laboratories Recent Developments
  49. 7.9 Impact Analytical
  50. 7.9.1 Impact Analytical Company Information
  51. 7.9.2 Impact Analytical Business Overview
  52. 7.9.3 Impact Analytical Drug Stability Testing Services Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Impact Analytical Drug Stability Testing Services Product Portfolio
  54. 7.9.5 Impact Analytical Recent Developments
  55. 7.10 Prolytix
  56. 7.10.1 Prolytix Company Information
  57. 7.10.2 Prolytix Business Overview
  58. 7.10.3 Prolytix Drug Stability Testing Services Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Prolytix Drug Stability Testing Services Product Portfolio
  60. 7.10.5 Prolytix Recent Developments
  61. 7.11 Almac
  62. 7.11.1 Almac Company Information
  63. 7.11.2 Almac Business Overview
  64. 7.11.3 Almac Drug Stability Testing Services Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Almac Drug Stability Testing Services Product Portfolio
  66. 7.11.5 Almac Recent Developments
  67. 7.12 Galbraith Laboratories, Inc.
  68. 7.12.1 Galbraith Laboratories, Inc. Company Information
  69. 7.12.2 Galbraith Laboratories, Inc. Business Overview
  70. 7.12.3 Galbraith Laboratories, Inc. Drug Stability Testing Services Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Galbraith Laboratories, Inc. Drug Stability Testing Services Product Portfolio
  72. 7.12.5 Galbraith Laboratories, Inc. Recent Developments
  73. 7.13 Element
  74. 7.13.1 Element Company Information
  75. 7.13.2 Element Business Overview
  76. 7.13.3 Element Drug Stability Testing Services Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Element Drug Stability Testing Services Product Portfolio
  78. 7.13.5 Element Recent Developments
8 North America
  1. 8.1 North America Drug Stability Testing Services Revenue (2021-2032)
  2. 8.2 North America Drug Stability Testing Services Revenue by Type (2021-2032)
  3. 8.2.1 North America Drug Stability Testing Services Revenue by Type (2021-2026)
  4. 8.2.2 North America Drug Stability Testing Services Revenue by Type (2027-2032)
  5. 8.3 North America Drug Stability Testing Services Revenue Share by Type (2021-2032)
  6. 8.4 North America Drug Stability Testing Services Revenue by Application (2021-2032)
  7. 8.4.1 North America Drug Stability Testing Services Revenue by Application (2021-2026)
  8. 8.4.2 North America Drug Stability Testing Services Revenue by Application (2027-2032)
  9. 8.5 North America Drug Stability Testing Services Revenue Share by Application (2021-2032)
  10. 8.6 North America Drug Stability Testing Services Revenue by Country
  11. 8.6.1 North America Drug Stability Testing Services Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Drug Stability Testing Services Revenue by Country (2021-2026)
  13. 8.6.3 North America Drug Stability Testing Services Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Drug Stability Testing Services Revenue (2021-2032)
  2. 9.2 Europe Drug Stability Testing Services Revenue by Type (2021-2032)
  3. 9.2.1 Europe Drug Stability Testing Services Revenue by Type (2021-2026)
  4. 9.2.2 Europe Drug Stability Testing Services Revenue by Type (2027-2032)
  5. 9.3 Europe Drug Stability Testing Services Revenue Share by Type (2021-2032)
  6. 9.4 Europe Drug Stability Testing Services Revenue by Application (2021-2032)
  7. 9.4.1 Europe Drug Stability Testing Services Revenue by Application (2021-2026)
  8. 9.4.2 Europe Drug Stability Testing Services Revenue by Application (2027-2032)
  9. 9.5 Europe Drug Stability Testing Services Revenue Share by Application (2021-2032)
  10. 9.6 Europe Drug Stability Testing Services Revenue by Country
  11. 9.6.1 Europe Drug Stability Testing Services Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Drug Stability Testing Services Revenue by Country (2021-2026)
  13. 9.6.3 Europe Drug Stability Testing Services Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Drug Stability Testing Services Revenue (2021-2032)
  2. 10.2 China Drug Stability Testing Services Revenue by Type (2021-2032)
  3. 10.2.1 China Drug Stability Testing Services Revenue by Type (2021-2026)
  4. 10.2.2 China Drug Stability Testing Services Revenue by Type (2027-2032)
  5. 10.3 China Drug Stability Testing Services Revenue Share by Type (2021-2032)
  6. 10.4 China Drug Stability Testing Services Revenue by Application (2021-2032)
  7. 10.4.1 China Drug Stability Testing Services Revenue by Application (2021-2026)
  8. 10.4.2 China Drug Stability Testing Services Revenue by Application (2027-2032)
  9. 10.5 China Drug Stability Testing Services Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Drug Stability Testing Services Revenue (2021-2032)
  2. 11.2 Asia Drug Stability Testing Services Revenue by Type (2021-2032)
  3. 11.2.1 Asia Drug Stability Testing Services Revenue by Type (2021-2026)
  4. 11.2.2 Asia Drug Stability Testing Services Revenue by Type (2027-2032)
  5. 11.3 Asia Drug Stability Testing Services Revenue Share by Type (2021-2032)
  6. 11.4 Asia Drug Stability Testing Services Revenue by Application (2021-2032)
  7. 11.4.1 Asia Drug Stability Testing Services Revenue by Application (2021-2026)
  8. 11.4.2 Asia Drug Stability Testing Services Revenue by Application (2027-2032)
  9. 11.5 Asia Drug Stability Testing Services Revenue Share by Application (2021-2032)
  10. 11.6 Asia Drug Stability Testing Services Revenue by Country
  11. 11.6.1 Asia Drug Stability Testing Services Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Drug Stability Testing Services Revenue by Country (2021-2026)
  13. 11.6.3 Asia Drug Stability Testing Services Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Drug Stability Testing Services Revenue (2021-2032)
  2. 12.2 SAMEA Drug Stability Testing Services Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Drug Stability Testing Services Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Drug Stability Testing Services Revenue by Type (2027-2032)
  5. 12.3 SAMEA Drug Stability Testing Services Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Drug Stability Testing Services Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Drug Stability Testing Services Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Drug Stability Testing Services Revenue by Application (2027-2032)
  9. 12.5 SAMEA Drug Stability Testing Services Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Drug Stability Testing Services Revenue by Country
  11. 12.6.1 SAMEA Drug Stability Testing Services Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Drug Stability Testing Services Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Drug Stability Testing Services Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst